Epidemiology

Gastrointestinal melanoma is a rare condition that primarily occurs when melanoma from another part of the body spreads to the digestive system. Malignant melanoma, which is a cancer that develops from pigment-producing cells called melanocytes, has become the fifth most frequent cancer in the United Kingdom^[1]. Among all cancers, melanoma stands out as the most common type to spread to the gastrointestinal tract^[1][2].

When examining where melanoma spreads within the digestive system, the small bowel is the most frequently affected area, accounting for approximately 35 to 50 percent of cases. This is followed by the colon at around 28 to 31 percent, the stomach at 22 to 26 percent, and the rectum at about 5 to 25 percent^[4][7]. True primary melanoma—meaning melanoma that originates directly in the gastrointestinal tract rather than spreading from elsewhere—is exceptionally rare. Most melanomas found in the stomach and intestines are actually metastases, which are cancer cells that have traveled from a primary tumor in another location, most commonly the skin^[3].

Looking at the broader category of mucosal melanomas—melanomas that develop in the moist linings of body cavities including the gastrointestinal, respiratory, and genitourinary tracts—these account for only about one percent of all melanomas^[4][8]. Among mucosal melanomas, anorectal melanomas are by far the most common and most studied type within the gastrointestinal system^[4].

Research shows that mucosal melanomas generally affect older individuals, typically those over 70 years of age. These melanomas tend to occur more commonly in non-Hispanic white females, with a female-to-male ratio of approximately 1.8 to 1.0. This gender distribution differs from cutaneous (skin) melanoma, which has a male-to-female ratio of 1.2 to 1.0^[4][8]. Interestingly, head and neck mucosal melanomas have been observed in younger populations^[4][8].

Causes

The causes of gastrointestinal melanoma differ depending on whether it is a primary tumor or a metastasis. The vast majority of melanomas found in the gastrointestinal tract are metastases from cutaneous melanoma, meaning they originated as skin cancer that later spread^[3]. Primary cutaneous melanoma is strongly linked to exposure to ultraviolet rays, fair skin complexion, and a personal or family history of melanoma^[2][9].

When melanoma develops in the skin, it has a particular tendency to spread through the body’s lymphatic system and bloodstream. The cancer cells can invade locally, move through lymph nodes, and eventually reach distant organs including the gastrointestinal tract^[2][9]. Common sites where melanoma spreads include the liver, lungs, skin, and brain, with the gastrointestinal tract being a less common but significant destination^[2][9].

Primary gastrointestinal mucosal melanomas—those that originate directly in the digestive tract—are much rarer and their causes are not as well understood. Unlike skin melanomas, there is no obvious attributable risk factor like ultraviolet light exposure. Several theories attempt to explain their development. One theory suggests that melanoblast cells, which are precursors to melanocytes, might migrate from the neural crest during embryonic development and later undergo malignant transformation in the gastrointestinal tract^[4][8].

Other researchers believe these cancers might arise from malignant transformation of enteric neuroendocrine tissues or from neuroblastic Schwann cells of the intestinal autonomous nervous system^[4][8]. Additionally, epidemiological studies have shown a higher risk of anorectal mucosal melanomas in patients with HIV infection, suggesting that immune system status may play a role in certain cases^[4][8].

At the molecular level, mucosal melanomas appear to have different genetic characteristics compared to skin melanomas. They show a higher frequency of atypical BRAF and NRAS mutations, which are changes in genes that control cell growth. These unusual genetic patterns may contribute to the more aggressive behavior and poorer clinical outcomes seen in mucosal melanomas compared to their cutaneous counterparts^[4][8].

Risk Factors

Several factors increase the risk of developing melanoma that can potentially spread to the gastrointestinal tract. For cutaneous melanoma—the most common source of gastrointestinal metastases—the major risk factors include exposure to ultraviolet radiation from sunlight or tanning beds, having fair skin, and having a prior personal or family history of melanoma^[2][9].

Patients who have already been diagnosed with melanoma, particularly those with stage II to stage IV disease, face a higher risk of developing metastatic disease that could affect the gastrointestinal tract^[14]. The severity and likelihood of spread depend heavily on the stage of the original cancer. Advanced stages of melanoma carry a much greater risk of the cancer cells traveling to distant organs, including the stomach, intestines, and other parts of the digestive system.

For primary mucosal melanomas of the gastrointestinal tract, age is a significant risk factor, with these cancers occurring more commonly in individuals over 70 years old^[4][8]. Gender also plays a role, with mucosal melanomas appearing more frequently in females. People with HIV infection have been found to have a higher risk of developing anorectal mucosal melanomas, suggesting that immune system compromise may increase susceptibility^[4][8].

Having a history of melanoma of any type places individuals at increased risk for gastrointestinal involvement. This is particularly true for those who had deep primary tumors or who experienced lymph node involvement at the time of their initial diagnosis. The deeper the original melanoma penetrated into the skin layers, and the more lymph nodes that were affected, the higher the chance that cancer cells could have spread to other parts of the body, including the gastrointestinal tract.

Symptoms

Gastrointestinal melanoma often presents with vague and nonspecific symptoms that can make diagnosis challenging. Many patients with melanoma metastases in the gastrointestinal tract may remain clinically silent for some time, showing no obvious signs of disease^[2][9]. This silent period can occur even years after the initial melanoma diagnosis, which is why ongoing monitoring is important for melanoma patients.

When symptoms do appear, they can vary depending on the location and extent of the gastrointestinal involvement. Common symptoms include abdominal pain, which can range from mild discomfort to severe cramping. Many patients experience nausea and vomiting, which can affect their ability to eat and maintain proper nutrition^[7][14]. Weight loss is another frequent symptom, often occurring alongside decreased appetite and difficulty eating.

Gastrointestinal bleeding is a particularly significant symptom that should prompt immediate medical attention. This can manifest as melena, which is black, tarry stools indicating bleeding from the upper digestive tract, or as hematochezia, which is bright red blood in the stool suggesting bleeding from the lower digestive tract^[3][7]. Some patients may experience both types of bleeding at different times. The bleeding can lead to anemia, causing fatigue, dizziness, and weakness.

Additional symptoms can include changes in bowel habits, such as constipation or diarrhea, and a general feeling of not being well. Some patients report epigastric pain, which is discomfort in the upper central area of the abdomen. In severe cases, patients may present with syncope (fainting) due to significant blood loss^[7]. The symptoms can sometimes mimic other common gastrointestinal conditions, which can delay diagnosis if healthcare providers are not aware of the patient’s melanoma history.

It’s particularly important to note that these symptoms are nonspecific, meaning they can occur with many other gastrointestinal conditions. However, in anyone with a history of melanoma, even distant history, these symptoms should raise suspicion for possible gastrointestinal metastases and warrant thorough investigation^[14].

Prevention

Prevention of gastrointestinal melanoma primarily focuses on preventing the initial development of melanoma and monitoring for spread in those who have already been diagnosed. For primary melanoma prevention, avoiding or limiting exposure to ultraviolet radiation is crucial. This includes practicing sun safety by wearing protective clothing, using broad-spectrum sunscreen, avoiding tanning beds, and seeking shade during peak sun hours^[2][9].

Early detection of cutaneous melanoma through regular skin examinations is one of the most effective preventive strategies. People should be aware of changes in existing moles or the appearance of new, unusual skin lesions. Healthcare providers recommend that individuals at high risk for melanoma undergo regular skin checks by dermatologists. Catching melanoma at an early stage, before it has a chance to spread, significantly reduces the risk of gastrointestinal and other metastases.

For individuals who have already been diagnosed with melanoma, ongoing surveillance and monitoring are essential components of preventing complications from gastrointestinal spread. Regular follow-up appointments and imaging studies help detect metastases early, when they may be more treatable. The standard modality for staging and surveillance of melanoma patients is CT imaging, which can identify gastrointestinal lesions in most cases^[2][9].

Early diagnosis of gastrointestinal metastases is critical to avoid emergency hospitalizations and enable potentially curative surgical interventions in appropriate cases^[2][9]. Patients with a history of melanoma should maintain open communication with their healthcare team and promptly report any gastrointestinal symptoms, no matter how minor they may seem.

While there are no specific lifestyle changes proven to prevent melanoma from spreading to the gastrointestinal tract, maintaining overall health through good nutrition, regular exercise, and stress management may support the immune system. Some research suggests that these factors, along with the gut microbiome, might influence treatment outcomes for melanoma patients, though more studies are needed to fully understand these relationships.

Pathophysiology

The pathophysiology of gastrointestinal melanoma involves understanding how cancer cells reach and affect the digestive system. When melanoma spreads to the gastrointestinal tract, it typically does so through hematogenous spread, meaning cancer cells travel through the bloodstream, or through lymphatic spread, where cancer cells move through the lymphatic vessels^[2][9].

Melanoma has a particular affinity for spreading to the small bowel, followed by the stomach and large intestine^[1]. This pattern of spread appears to be related to the rich blood supply of these organs and the characteristics of melanoma cells that allow them to preferentially attach and grow in these locations. The gastrointestinal tract receives a significant portion of cardiac output, which may explain why circulating melanoma cells frequently lodge there.

Once melanoma cells reach the gastrointestinal tract, they can cause problems through several mechanisms. The growing tumors can cause mechanical obstruction, where the cancer mass physically blocks the passage of food and digestive materials through the intestines. This can lead to symptoms like abdominal pain, constipation, and in severe cases, complete bowel obstruction requiring emergency intervention.

The tumors can also erode into blood vessels, leading to gastrointestinal bleeding. This bleeding can be acute and severe, or it can be chronic and subtle, gradually leading to anemia over time. The ulceration of these tumors creates raw, bleeding surfaces within the digestive tract. Some patients present with large necrotic ulcerated masses that can be seen during endoscopic examination^[3].

Gastrointestinal mucosal melanomas have a more aggressive course compared to cutaneous melanomas, partly due to their rapid lymphovascular spread. The rich lymphatic and vascular networks in the gastrointestinal tract provide ample opportunity for cancer cells to invade and spread to nearby and distant sites^[4][8]. Studies show that metastasis can occur in 50 to 90 percent of cases despite aggressive surgical approaches, highlighting the aggressive nature of this disease.

Interestingly, approximately 40 percent of melanoma lesions in the gastrointestinal tract can be amelanotic, meaning they lack the typical dark pigmentation associated with melanoma^[4][8]. This characteristic can make diagnosis more challenging, as physicians and pathologists may not immediately recognize these lesions as melanoma without special staining techniques. The tumors require immunohistochemistry staining with markers like S-100, HMB-45, and Melan A to confirm the diagnosis^[3][7].

The molecular biology of gastrointestinal mucosal melanomas differs from cutaneous melanomas. These tumors show a higher frequency of atypical BRAF and NRAS mutations, which are genetic changes affecting cell signaling pathways that control growth and division. These unique genetic characteristics contribute to their more aggressive behavior and poorer prognosis compared to skin melanomas^[4][8].